Tissue Fragment Implantation
Tissue Fragment Implantation - Related Videos
07:09
Isolation of Murine Adipose Tissue-derived Microvascular Fragments as Vascularization Units for Tissue Engineering
0 Views •
Cited by 58 •
2017
We present a protocol to isolate adipose tissue-derived microvascular fragments that represent promising vascularization units. They can be rapidly isolated, do not require in vitro processing and, thus, may be used for one-step prevascularization in different fields of tissue engineering.
07:59
Implantation of Engineered Tissue in the Rat Heart
0 Views •
Cited by 4 •
2009
Here, we describe a cardiac surgical procedure to implant engineered tissue in the atrioventricular (AV)-groove of an adult Lewis rat.
02:31
Habitat Fragmentation
0 Views •
2020
Habitat fragmentation describes the division of a more extensive, continuous habitat into smaller, discontinuous areas. Human activities such as land conversion, as well as slower geological processes leading to changes in the physical environment, are the two leading causes of habitat fragmentation. The fragmentation process typically follows the same steps: perforation, dissection, fragmentation, shrinkage, and attrition. Perforation and dissection often occur during the initial stages of...
11:31
Intact Histological Characterization of Brain-implanted Microdevices and Surrounding Tissue
0 Views •
Cited by 6 •
2013
Here we present a histological method for capturing, labeling, optically clearing, and imaging the intact brain tissue interface around chronically implanted microdevices in rodent brain tissue. Results from the techniques comprising this method are useful for understanding the impact of various penetrating brain-implants on their surrounding tissue.
10:18
Fiber-optic Implantation for Chronic Optogenetic Stimulation of Brain Tissue
0 Views •
Cited by 50 •
2012
The development of optogenetics now provides the means to precisely stimulate genetically defined neurons and circuits, both in vitro and in vivo. Here we describe the assembly and implantation of a fiber optic for chronic photostimulation of brain tissue.
FAQs
Preserving tumor architecture and heterogeneity can improve the relevance of the resulting model to the original cancer. Implanted fragments may retain features of the source tumor while expanding in the host, allowing investigators to examine progression and treatment response in a setting that reflects more of the tumor’s biological complexity. This is especially important for preclinical interpretation.
The site provides experimental context for how the fragment grows and interacts with its surroundings. Subcutaneous placement offers one setting, whereas an anatomically relevant site can more closely represent the tissue environment associated with the tumor. Comparing these contexts can help investigators examine growth, biological behavior, and interactions with surrounding tissue.
Successful establishment is reflected by the fragment surviving, developing a blood supply, and expanding within the host. Investigators can then assess whether the growing tumor continues to retain features of the original tissue. These outcomes matter because they determine whether the implantation supports meaningful studies of progression, therapeutic response, or drug resistance.
A basic workflow transfers a tissue piece into a living host, commonly an immunodeficient animal in cancer research, places it subcutaneously or at an anatomically relevant site, and follows its establishment and expansion. The resulting growth is evaluated for survival and biological behavior, while retained tumor features support analyses of progression, treatment response, resistance, or tissue interactions.
Researchers would choose Tissue Fragment Implantation when they need a cancer model that can support questions about tumor progression, response to therapy, or the emergence of drug resistance. Because fragments can preserve aspects of the original tumor’s architecture and heterogeneity, the approach is also useful for studying how tumors interact with surrounding tissue during growth.
Patient-derived xenograft models created through this approach can be used to investigate how a tumor progresses, responds to treatment, and develops drug resistance. They also provide a framework for examining interactions between the tumor and surrounding tissue. Their value comes from combining tumor expansion in a living host with retention of selected features from the original tumor.